FIELD: pharmaceuticals; medicine.
SUBSTANCE: group of inventions relates to a conjugate having structure (I): [(P)-(L)]m-(T) (I), where: (L) is a linker; (T) is an antibody or antibody fragment which specifically binds to an antigen, present on tumor cell; m is integer from 1 to 10 and (P) has structure (VI) or (XId):
,
and (L)-(T) has structure (III):
,
where each AA independently represents an amino acid; x is integer from 0 to 25 and (L') is optionally a linker (L) residue. Group of inventions also relates to a pharmaceutical composition, containing said conjugate, to using a conjugate for preparing a drug for treating cancer in a mammal and a method of treating cancer in a mammal, comprising administering an effective amount of the conjugate.
EFFECT: disclosed are sulphonamide-containing binding systems for drug conjugates.
27 cl, 17 dwg, 3 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
CYTOTOXIC AND ANTIMITOTIC COMPOUNDS AND METHODS OF USING THEM | 2015 |
|
RU2723651C2 |
ANTIFIBROUS PYRIDINONES | 2015 |
|
RU2692485C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2687093C1 |
MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
MACROCYCLIC WIDE-RANGE ANTIBIOTICS | 2018 |
|
RU2779477C2 |
THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2695664C1 |
MACROCYCLIC ANTIBIOTICS OF WIDE RANGE OF ACTIONS | 2016 |
|
RU2766543C2 |
Authors
Dates
2020-08-05—Published
2014-12-29—Filed